10 results on '"Wallace, Callen T."'
Search Results
2. The Impaired Neurodevelopment of Human Neural Rosettes in HSV-1-Infected Early Brain Organoids.
- Author
-
D'Aiuto, Leonardo, Caldwell, Jill K., Wallace, Callen T., Grams, Tristan R., Wesesky, Maribeth A., Wood, Joel A., Watkins, Simon C., Kinchington, Paul R., Bloom, David C., and Nimgaonkar, Vishwajit L.
- Subjects
- *
PLURIPOTENT stem cells , *NEURAL stem cells , *INDUCED pluripotent stem cells , *HERPES simplex virus , *NEURAL development , *ORGANOIDS , *NEURONAL differentiation - Abstract
Intrauterine infections during pregnancy by herpes simplex virus (HSV) can cause significant neurodevelopmental deficits in the unborn/newborn, but clinical studies of pathogenesis are challenging, and while animal models can model some aspects of disease, in vitro studies of human neural cells provide a critical platform for more mechanistic studies. We utilized a reductionist approach to model neurodevelopmental outcomes of HSV-1 infection of neural rosettes, which represent the in vitro equivalent of differentiating neural tubes. Specifically, we employed early-stage brain organoids (ES-organoids) composed of human induced pluripotent stem cells (hiPSCs)-derived neural rosettes to investigate aspects of the potential neuropathological effects induced by the HSV-1 infections on neurodevelopment. To allow for the long-term differentiation of ES-organoids, viral infections were performed in the presence of the antiviral drug acyclovir (ACV). Despite the antiviral treatment, HSV-1 infection caused organizational changes in neural rosettes, loss of structural integrity of infected ES-organoids, and neuronal alterations. The inability of ACV to prevent neurodegeneration was associated with the generation of ACV-resistant mutants during the interaction of HSV-1 with differentiating neural precursor cells (NPCs). This study models the effects of HSV-1 infection on the neuronal differentiation of NPCs and suggests that this environment may allow for accelerated development of ACV-resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. PLA2G6 guards placental trophoblasts against ferroptotic injury.
- Author
-
Beharier, Ofer, Tyurin, Vladimir A., Goff, Julie P., Guerrero-Santoro, Jennifer, Kazuhiro Kajiwara, Tianjiao Chu, Tyurina, Yulia Y., St Croix, Claudette M., Wallace, Callen T., Parry, Samuel, Parks, W. Tony, Kagan, Valerian E., and Sadovsky, Yoel
- Subjects
- *
GLUTATHIONE peroxidase , *PREMATURE labor , *WOUNDS & injuries , *CELL death , *OXIDATIVE stress - Abstract
The recently identified ferroptotic cell death is characterized by excessive accumulation of hydroperoxy-arachidonoyl (C20:4)- or adrenoyl (C22:4)- phosphatidylethanolamine (Hp-PE). The seleniumdependent glutathione peroxidase 4 (GPX4) inhibits ferroptosis, converting unstable ferroptotic lipid hydroperoxides to nontoxic lipid alcohols in a tissue-specificmanner. While placental oxidative stress and lipotoxicity are hallmarks of placental dysfunction, the possible role of ferroptosis in placental dysfunction is largely unknown. We found that spontaneous preterm birth is associated with ferroptosis and that inhibition of GPX4 causes ferroptotic injury in primary human trophoblasts and during mouse pregnancy. Importantly, we uncovered a role for the phospholipase PLA2G6 (PNPLA9, iPLA2beta), known to metabolize Hp-PE to lyso-PE and oxidized fatty acid, in mitigating ferroptosis induced by GPX4 inhibition in vitro or by hypoxia/ reoxygenation injury in vivo. Together, we identified ferroptosis signaling in the human and mouse placenta, established a role for PLA2G6 in attenuating trophoblastic ferroptosis, and provided mechanistic insights into the ill-defined placental lipotoxicity that may inspire PLA2G6-targeted therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Live-cell imaging and analysis reveal cell phenotypic transition dynamics inherently missing in snapshot data.
- Author
-
Weikang Wang, Diana Douglas, Jingyu Zhang, Kumari, Sangeeta, Enuameh, Metewo Selase, Yan Dai, Wallace, Callen T., Watkins, Simon C., Weiguo Shu, and Jianhua Xing
- Subjects
- *
CELL analysis , *IMAGE analysis , *EPITHELIAL-mesenchymal transition - Abstract
The article discusses single-cell techniques catalyze an emerging field of studying how cells convert from one phenotype to another, in a step-by-step process. Topics include an A549 VIM-RFP epithelial-to-mesenchymal transition (EMT) reporter cell line, live-cell trajectories reveal parallel paths of EMT missing from snapshot data due to cell-cell dynamic heterogeneity; and cell phenotypic transition taking place for differentiated cells under physiological and pathological conditions.
- Published
- 2020
- Full Text
- View/download PDF
5. Ribosome-associated vesicles: A dynamic subcompartment of the endoplasmic reticulum in secretory cells.
- Author
-
Carter, Stephen D., Hampton, Cheri M., Langlois, Robert, Melero, Roberto, Farino, Zachary J., Calderon, Michael J., Wen Li, Wallace, Callen T., Tran, Ngoc Han, Grassucci, Robert A., Siegmund, Stephanie E., Pemberton, Joshua, Morgenstern, Travis J., Eisenman, Leanna, Aguilar, Jenny I., Greenberg, Nili L., Levy, Elana S., Yi, Edward, Mitchell, William G., and Rice, William J.
- Subjects
- *
ENDOPLASMIC reticulum , *CO-cultures , *PIXELS , *UNFOLDED protein response , *LYSIS - Published
- 2020
- Full Text
- View/download PDF
6. The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8+ Memory T Cell Maintenance and Secondary Response to Infection.
- Author
-
Piccirillo, Ann R., Hyzny, Eric J., Beppu, Lisa Y., Menk, Ashley V., Wallace, Callen T., Hawse, William F., Buechel, Heather M., Wong, Bernice H., Juat Chin Foo, Cazenave-Gassiot, Amaury, Wenk, Markus R., Delgoffe, Greg M., Watkins, Simon C., Silver, David L., and D'Cruz, Louise M.
- Subjects
- *
T cells , *BIOLOGICAL transport , *FATTY acids , *AMINO acids - Abstract
Access to nutrients is critical for an effective T cell immune response to infection. Although transporters for sugars and amino acids have previously been described in the context of the CD8+ T cell immune response, the active transport of exogenous fatty acids has remained enigmatic. In this study, we discovered that the sodium-dependent lysophosphatidylcholine (LPC) transporter major facilitator superfamily domain containing 2A (MFSD2A) is upregulated on activated CD8+ T cells and is required for memory T cell maintenance. MFSD2A deficiency in mice resulted in decreased import of LPC esterified to long chain fatty acids into activated CD8+ T cells, and MFSD2A-deficient cells are at a competitive disadvantage resulting in reduced memory T cell formation and maintenance and reduced response to secondary infection. Mechanistically, import of LPCs was required to maintain T cell homeostatic turnover, which when lost resulted in a decreased memory T cell pool and thus a reduced secondary response to repeat infection. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Compensation of select proteostasis networks after Hsp70 inhibition in cancer.
- Author
-
Sannino, Sara, Guerriero, Christopher J., Sabnis, Amit J., Stolz, Donna Beer, Wallace, Callen T., Wipf, Peter, Watkins, Simon C., Bivona, Trever G., and Brodsky, Jeffrey L.
- Subjects
- *
HSP70 heat-shock proteins , *PROTEOLYSIS , *AUTOPHAGY - Abstract
Cancer cells thrive when challenged with proteotoxic stress by inducing components of the protein folding, proteasome, autophagy, and unfolded protein response (UPR) pathways. Consequently, specific molecular chaperones have been validated as targets for anti-cancer therapies. For example, inhibition of Hsp70 in rhabdomyosarcoma triggers UPR induction and apoptosis. To define how these cancer cells respond to compromised proteostasis, we compared rhabdomyosarcoma cells that were sensitive (RMS13) or resistant (RMS13-R) to an Hsp70 inhibitor, MAL3-101. We discovered that endoplasmic reticulum associated degradation (ERAD) and autophagy were activated in RMS13-R cells, suggesting that resistant cells overcome Hsp70 ablation by increasing misfolded protein degradation. Indeed, RMS13-R cells degraded ERAD substrates more rapidly than RMS cells and induced the autophagy pathway. Surprisingly, inhibition of the proteasome or ERAD had no effect on RMS13-R cell survival, but silencing of select autophagy components or treatment with autophagy inhibitors restored MAL3-101 sensitivity and led to apoptosis. These data indicate a route through which cancer cells overcome a chaperone-based therapy, define how cells can adapt to Hsp70 inhibition, and demonstrate the value of combined chaperone and autophagy-based therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
8. Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps.
- Author
-
Boone, Brian A., Murthy, Pranav, Miller-Ocuin, Jennifer, Doerfler, W. Reed, Ellis, Jarrod T., Liang, Xiaoyan, Ross, Mark A., Wallace, Callen T., Sperry, Jason L., Lotze, Michael T., Neal, Matthew D., Zeh, Herbert J., and Zeh, Herbert J 3rd
- Subjects
- *
CHLOROQUINE , *PANCREATIC cancer treatment , *NEUTROPHILS , *HIGH mobility group proteins , *ENZYME-linked immunosorbent assay , *THERAPEUTICS - Abstract
Background: The hypercoagulable state associated with pancreatic adenocarcinoma (PDA) results in increased risk of venous thromboembolism, leading to substantial morbidity and mortality. Recently, neutrophil extracellular traps (NETs), whereby activated neutrophils release their intracellular contents containing DNA, histones, tissue factor, high mobility group box 1 (HMGB1) and other components have been implicated in PDA and in cancer-associated thrombosis.Methods: Utilizing an orthotopic murine PDA model in C57/Bl6 mice and patient correlative samples, we studied the role of NETs in PDA hypercoagulability and targeted this pathway through treatment with the NET inhibitor chloroquine. PAD4 and RAGE knockout mice, deficient in NET formation, were used to study the role of NETs in platelet aggregation, release of tissue factor and hypercoagulability. Platelet aggregation was assessed using collagen-activated impedance aggregometry. Levels of circulating tissue factor, the initiator of extrinsic coagulation, were measured using ELISA. Thromboelastograms (TEGs) were performed to assess hypercoagulability and changes associated with treatment. Correlative data and samples from a randomized clinical trial of preoperative gemcitabine/nab-paclitaxel with and without hydroxychloroquine were studied and the impact of treatment on venous thromboembolism (VTE) rate was evaluated.Results: The addition of NETs to whole blood stimulated platelet activation and aggregation. DNA and the receptor for advanced glycation end products (RAGE) were necessary for induction of NET associated platelet aggregation. PAD4 knockout tumor-burdened mice, unable to form NETs, had decreased aggregation and decreased circulating tissue factor. The NET inhibitor chloroquine reduces platelet aggregation, reduces circulating tissue factor and decreases hypercoagulability on TEG. Review of correlative data from patients treated on a randomized protocol of preoperative chemotherapy with and without hydroxychloroquine demonstrated a reduction in peri-operative VTE rate from 30 to 9.1% with hydroxychloroquine that neared statistical significance (p = 0.053) despite the trial not being designed to study VTE.Conclusion: NETs promote hypercoagulability in murine PDA through stimulation of platelets and release of tissue factor. Chloroquine inhibits NETs and diminishes hypercoagulability. These findings support clinical study of chloroquine to lower rates of venous thromboembolism in patients with cancer.Trial Registration: This study reports correlative data from two clinical trials that registered with clinicaltrials.gov, NCT01128296 (May 21, 2010) and NCT01978184 (November 7, 2013). [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
9. RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.
- Author
-
Barroso-González, Jonathan, García-Expósito, Laura, Hoang, Song My, Lynskey, Michelle L., Roncaioli, Justin L., Ghosh, Arundhati, Wallace, Callen T., Modesti, Mauro, Bernstein, Kara A., Sarkar, Saumendra N., Watkins, Simon C., and O'Sullivan, Roderick J.
- Subjects
- *
TELOMERES , *DNA synthesis , *CANCER cell proliferation , *DNA damage , *CANCER cells - Abstract
Alternative lengthening of telomeres (ALT) is a homology-directed repair (HDR) mechanism of telomere elongation that controls proliferation in aggressive cancers. We show that the disruption of RAD51-associated protein 1 (RAD51AP1) in ALT+ cancer cells leads to generational telomere shortening. This is due to RAD51AP1's involvement in RAD51-dependent homologous recombination (HR) and RAD52-POLD3-dependent break induced DNA synthesis. RAD51AP1 KO ALT+ cells exhibit telomere dysfunction and cytosolic telomeric DNA fragments that are sensed by cGAS. Intriguingly, they activate ULK1-ATG7-dependent autophagy as a survival mechanism to mitigate DNA damage and apoptosis. Importantly, RAD51AP1 protein levels are elevated in ALT+ cells due to MMS21 associated SUMOylation. Mutation of a single SUMO-targeted lysine residue perturbs telomere dynamics. These findings indicate that RAD51AP1 is an essential mediator of the ALT mechanism and is co-opted by post-translational mechanisms to maintain telomere length and ensure proliferation of ALT+ cancer cells. • Disruption of RAD51AP1 inhibits telomere homology-directed repair in ALT cancer cells • cGAS-ULK1-ATG7-dependent autophagy is activated upon telomere dysfunction • RAD51AP1 is specifically stabilized and regulated by SUMOylation Barroso-González et al. identify that disruption of the HR accessory factor RAD51AP1 disrupts ALT telomere elongation, causing telomere damage and fragmentation. Rather than dying, these cancer cells activate autophagy as a survival mechanism. The importance of RAD51AP1 in ALT cancer cells is underscored by its specific stabilization by SUMOylated mediated mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.
- Author
-
Weinstein, Aliyah M., Chen, Lu, Brzana, Emily A., Patil, Prashanti R., Taylor, Jennifer L., Fabian, Kellsye L., Wallace, Callen T., Jones, Sabrina D., Watkins, Simon C., Lu, Binfeng, Stroncek, David F., Denning, Timothy L., Fu, Yang-Xin, Cohen, Peter A., and Storkus, Walter J.
- Subjects
- *
DENDRITIC cells , *ANTINEOPLASTIC agents , *DRUG efficacy - Abstract
We have previously reported that direct injection of dendritic cells (DC) engineered to express the Type-1 transactivator Tbet (i.e., DC.Tbet) into murine tumors results in antitumor efficacy in association with the development of structures resembling tertiary lymphoid organs (TLO) in the tumor microenvironment (TME). These TLO contained robust infiltrates of B cells, DC, NK cells, and T cells in proximity to PNAd+blood vessels; however, they were considered incomplete, since the recruited B cells failed to organize into classic germinal center-like structures. We now report that antitumor efficacy and TLO-inducing capacity of DC.Tbet-based i.t. therapy is operational in peripheral lymph node-deficient LTA−/−mice, and that it is highly dependent upon a direct Tbet target gene product, IL-36γ/IL-1F9. Intratumoral DC.Tbet fails to provide protection to tumor-bearing IL-36R−/−hosts, or to tumor-bearing wild-type recipient mice co-administered rmIL-1F5/IL-36RN, a natural IL-36R antagonist. Remarkably, the injection of tumors with DC engineered to secrete a bioactive form of mIL-36γ (DC.IL36γ) also initiated therapeutic TLO and slowed tumor progressionin vivo. Furthermore, DC.IL36γ cells strongly upregulated their expression of Tbet, suggesting that Tbet and IL-36γ cooperate to reinforce each other's expression in DC, rendering them competent to promote TLO formation in an “immunologically normalized,” therapeutic TME. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.